BCAX · Bicara Therapeutics Inc. · Investor Relations
$18.35
+0.88 (+5.04%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.22B
Shares
66.17M
Volume · Oct 20
493.42K
Avg daily vol (3M)
671.38K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-10 16:30 UTC | Guggenheim 3rd Annual Healthcare Innovation Conference | Conference |
| 2026-11-11 14:20 UTC | Stifel 2026 Healthcare Conference | Conference |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-09 | 2026 Cantor Global Healthcare Conference | Conference |
| 2026-08-11 | Bicara Therapeutics Q2 2026 Earnings Call | Earnings call |
| 2026-05-27 | TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA | Event |
| 2026-05-22 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-13 | BofA Securities Health Care Conference 2026 | Conference |
| 2026-05-11 | Bicara Therapeutics Q1 2026 Earnings Call | Earnings call |
| 2026-03-30 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.bicara.com/
Key facts
CIK
2023658
CUSIP
055477103
13F (30d)
11 filings
11 filers
Visit website
Investor relations